Results 71 to 79 of about 4,117 (79)

QSAR Prediction of Passive Permeability in the LLC‐PK1 Cell Line: Trends in Molecular Properties and Cross‐Prediction of Caco‐2 Permeabilities

Molecular Informatics, 2012
Edward C Sherer, Andreas Verras, Robert P Sheridan   +2 more
exaly  

Inhibition of Intracellular ROS Accumulation by Formononetin Attenuates Cisplatin-Mediated Apoptosis in LLC-PK1 Cells

International Journal of Molecular Sciences, 2018
Ji Hoon Song, Ki Sung Kang
exaly  

Inhibition of Na,K-ATPase Activates PI3 Kinase and Inhibits Apoptosis in LLC-PK1 Cells

Biochemical and Biophysical Research Communications, 2001
Tamas Balla
exaly  

Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines

European Journal of Pharmaceutical Sciences, 2000
exaly  

Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymerdoxorubicin (PK1)

Human and Experimental Toxicology, 1998
exaly  

Niosomes containing N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin (PK1): effect of method of preparation and choice of surfactant on niosome characteristics and a preliminary study of body distribution

International Journal of Pharmaceutics, 1997
exaly  

Pharmaceutical and biological characterisation of a doxorubicin-polymer conjugate (PK1) entrapped in sorbitan monostearate Span 60 niosomes

International Journal of Pharmaceutics, 1997
exaly  

Role of enhanced ceramide generation in DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells

Kidney International, 1998
exaly  

The Impact of Endogenous Breast Cancer Resistance Protein on Human P-Glycoprotein-Mediated Transport Assays Using LLC-PK1 Cells Transfected With Human P-Glycoprotein

Journal of Pharmaceutical Sciences, 2019
exaly